カテゴリー： LP Information, 世界, 部品/材料

世界のトシリズマブ市場予測 2023年-2029年

◆英語タイトル：Global Tocilizumab Market Growth 2023-2029
	◆商品コード：LP23JU0853 ◆発行会社（リサーチ会社）：LP Information ◆発行日：2023年5月 ◆ページ数：103 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など ◆産業分野：化学＆材料

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,660 ⇒換算￥556,320	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD5,490 ⇒換算￥834,480	見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）	USD7,320 ⇒換算￥1,112,640	見積依頼/購入/質問フォーム

★LP Informationに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界のトシリズマブ市場」は、過去の販売実績から2022年の世界のトシリズマブの総販売量を検討し、2023年から2029年の予測されるトシリズマブの販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別のトシリズマブの市場規模を掲載し、XXX百万米ドル規模の世界のトシリズマブ市場の詳細な分析を提供します。本インサイトレポートは、世界のトシリズマブ業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界のトシリズマブ市場における各社の独自のポジションをより深く理解するために、トシリズマブ製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界のトシリズマブ市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。トシリズマブの米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。トシリズマブの中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。トシリズマブのヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

トシリズマブの世界主要メーカーとしては、Bio-Rad Laboratories、 Bio-Techne、 BioVision、 Selleck Chemicals、 Biorbyt、 AbMole、 Biosynth Carbosynth、 SimSon Pharma、 BOC Sciences、 Clearsynth、 LifeSpan BioSciencesなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別のトシリズマブ市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査ではトシリズマブ市場をセグメンテーションし、種類別 (最小純度98%以下、最小純度98%-99%、最小純度99%以上)、用途別 (研究、医療)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：最小純度98%以下、最小純度98%-99%、最小純度99%以上

・用途別区分：研究、医療

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界のトシリズマブ市場の10年間の市場状況・展望は？
・世界および地域別に見たトシリズマブ市場成長の要因は何か？
・トシリズマブの市場機会はエンドマーケットの規模によってどのように変化するのか？
・トシリズマブのタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：トシリズマブの年間販売量2018-2029、地域別現状・将来分析
・トシリズマブの種類別セグメント：最小純度98%以下、最小純度98%-99%、最小純度99%以上
・トシリズマブの種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・トシリズマブの用途別セグメント：研究、医療
・トシリズマブの用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界のトシリズマブ市場
・企業別のグローバルトシリズマブ市場データ：2018-2023年の年間販売量、市場シェア
・企業別のトシリズマブの年間売上：2018-2023年の売上、市場シェア
・企業別のトシリズマブ販売価格
・主要企業のトシリズマブ生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

トシリズマブの地域別レビュー
・地域別のトシリズマブ市場規模2018-2023：年間販売量、売上
・主要国別のトシリズマブ市場規模2018-2023：年間販売量、売上
・南北アメリカのトシリズマブ販売の成長
・アジア太平洋のトシリズマブ販売の成長
・ヨーロッパのトシリズマブ販売の成長
・中東・アフリカのトシリズマブ販売の成長

南北アメリカ市場
・南北アメリカの国別のトシリズマブ販売量、売上（2018-2023）
・南北アメリカのトシリズマブの種類別販売量
・南北アメリカのトシリズマブの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別のトシリズマブ販売量、売上（2018-2023）
・アジア太平洋のトシリズマブの種類別販売量
・アジア太平洋のトシリズマブの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別のトシリズマブ販売量、売上（2018-2023）
・ヨーロッパのトシリズマブの種類別販売量
・ヨーロッパのトシリズマブの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別のトシリズマブ販売量、売上（2018-2023）
・中東・アフリカのトシリズマブの種類別販売量
・中東・アフリカのトシリズマブの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・トシリズマブの製造コスト構造分析
・トシリズマブの製造プロセス分析
・トシリズマブの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・トシリズマブの主要なグローバル販売業者
・トシリズマブの主要なグローバル顧客

地域別のトシリズマブ市場予測レビュー
・地域別のトシリズマブ市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・トシリズマブの種類別市場規模予測
・トシリズマブの用途別市場規模予測

主要企業分析
Bio-Rad Laboratories、 Bio-Techne、 BioVision、 Selleck Chemicals、 Biorbyt、 AbMole、 Biosynth Carbosynth、 SimSon Pharma、 BOC Sciences、 Clearsynth、 LifeSpan BioSciences
・企業情報
・トシリズマブ製品
・トシリズマブ販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Tocilizumab is a humanized monoclonal antibody resistant against the interleukin-6 receptor (IL-6R). It is an immunosuppressive agent commonly used for the treatment of rheumatoid arthritis (RA) and systemic juvenile idiopathic arthritis.
LPI (LP Information)’ newest research report, the “Tocilizumab Industry Forecast” looks at past sales and reviews total world Tocilizumab sales in 2022, providing a comprehensive analysis by region and market sector of projected Tocilizumab sales for 2023 through 2029. With Tocilizumab sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tocilizumab industry.
This Insight Report provides a comprehensive analysis of the global Tocilizumab landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tocilizumab portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Tocilizumab market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tocilizumab and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tocilizumab.
The global Tocilizumab market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Tocilizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tocilizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tocilizumab is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tocilizumab players cover Bio-Rad Laboratories, Bio-Techne, BioVision, Selleck Chemicals, Biorbyt, AbMole, Biosynth Carbosynth, SimSon Pharma and BOC Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tocilizumab market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segmentation by application
Research
Medical
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Bio-Rad Laboratories
Bio-Techne
BioVision
Selleck Chemicals
Biorbyt
AbMole
Biosynth Carbosynth
SimSon Pharma
BOC Sciences
Clearsynth
LifeSpan BioSciences
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tocilizumab market?
What factors are driving Tocilizumab market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tocilizumab market opportunities vary by end market size?
How does Tocilizumab break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Tocilizumab Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Tocilizumab by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Tocilizumab by Country/Region, 2018, 2022 & 2029
2.2 Tocilizumab Segment by Type
2.2.1 Min Purity Less Than 98%
2.2.2 Min Purity 98%-99%
2.2.3 Min Purity More Than 99%
2.3 Tocilizumab Sales by Type
2.3.1 Global Tocilizumab Sales Market Share by Type (2018-2023)
2.3.2 Global Tocilizumab Revenue and Market Share by Type (2018-2023)
2.3.3 Global Tocilizumab Sale Price by Type (2018-2023)
2.4 Tocilizumab Segment by Application
2.4.1 Research
2.4.2 Medical
2.5 Tocilizumab Sales by Application
2.5.1 Global Tocilizumab Sale Market Share by Application (2018-2023)
2.5.2 Global Tocilizumab Revenue and Market Share by Application (2018-2023)
2.5.3 Global Tocilizumab Sale Price by Application (2018-2023)
3 Global Tocilizumab by Company
3.1 Global Tocilizumab Breakdown Data by Company
3.1.1 Global Tocilizumab Annual Sales by Company (2018-2023)
3.1.2 Global Tocilizumab Sales Market Share by Company (2018-2023)
3.2 Global Tocilizumab Annual Revenue by Company (2018-2023)
3.2.1 Global Tocilizumab Revenue by Company (2018-2023)
3.2.2 Global Tocilizumab Revenue Market Share by Company (2018-2023)
3.3 Global Tocilizumab Sale Price by Company
3.4 Key Manufacturers Tocilizumab Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Tocilizumab Product Location Distribution
3.4.2 Players Tocilizumab Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tocilizumab by Geographic Region
4.1 World Historic Tocilizumab Market Size by Geographic Region (2018-2023)
4.1.1 Global Tocilizumab Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Tocilizumab Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Tocilizumab Market Size by Country/Region (2018-2023)
4.2.1 Global Tocilizumab Annual Sales by Country/Region (2018-2023)
4.2.2 Global Tocilizumab Annual Revenue by Country/Region (2018-2023)
4.3 Americas Tocilizumab Sales Growth
4.4 APAC Tocilizumab Sales Growth
4.5 Europe Tocilizumab Sales Growth
4.6 Middle East & Africa Tocilizumab Sales Growth
5 Americas
5.1 Americas Tocilizumab Sales by Country
5.1.1 Americas Tocilizumab Sales by Country (2018-2023)
5.1.2 Americas Tocilizumab Revenue by Country (2018-2023)
5.2 Americas Tocilizumab Sales by Type
5.3 Americas Tocilizumab Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Tocilizumab Sales by Region
6.1.1 APAC Tocilizumab Sales by Region (2018-2023)
6.1.2 APAC Tocilizumab Revenue by Region (2018-2023)
6.2 APAC Tocilizumab Sales by Type
6.3 APAC Tocilizumab Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Tocilizumab by Country
7.1.1 Europe Tocilizumab Sales by Country (2018-2023)
7.1.2 Europe Tocilizumab Revenue by Country (2018-2023)
7.2 Europe Tocilizumab Sales by Type
7.3 Europe Tocilizumab Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Tocilizumab by Country
8.1.1 Middle East & Africa Tocilizumab Sales by Country (2018-2023)
8.1.2 Middle East & Africa Tocilizumab Revenue by Country (2018-2023)
8.2 Middle East & Africa Tocilizumab Sales by Type
8.3 Middle East & Africa Tocilizumab Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Tocilizumab
10.3 Manufacturing Process Analysis of Tocilizumab
10.4 Industry Chain Structure of Tocilizumab
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Tocilizumab Distributors
11.3 Tocilizumab Customer
12 World Forecast Review for Tocilizumab by Geographic Region
12.1 Global Tocilizumab Market Size Forecast by Region
12.1.1 Global Tocilizumab Forecast by Region (2024-2029)
12.1.2 Global Tocilizumab Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Tocilizumab Forecast by Type
12.7 Global Tocilizumab Forecast by Application
13 Key Players Analysis
13.1 Bio-Rad Laboratories
13.1.1 Bio-Rad Laboratories Company Information
13.1.2 Bio-Rad Laboratories Tocilizumab Product Portfolios and Specifications
13.1.3 Bio-Rad Laboratories Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Bio-Rad Laboratories Main Business Overview
13.1.5 Bio-Rad Laboratories Latest Developments
13.2 Bio-Techne
13.2.1 Bio-Techne Company Information
13.2.2 Bio-Techne Tocilizumab Product Portfolios and Specifications
13.2.3 Bio-Techne Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Bio-Techne Main Business Overview
13.2.5 Bio-Techne Latest Developments
13.3 BioVision
13.3.1 BioVision Company Information
13.3.2 BioVision Tocilizumab Product Portfolios and Specifications
13.3.3 BioVision Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BioVision Main Business Overview
13.3.5 BioVision Latest Developments
13.4 Selleck Chemicals
13.4.1 Selleck Chemicals Company Information
13.4.2 Selleck Chemicals Tocilizumab Product Portfolios and Specifications
13.4.3 Selleck Chemicals Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Selleck Chemicals Main Business Overview
13.4.5 Selleck Chemicals Latest Developments
13.5 Biorbyt
13.5.1 Biorbyt Company Information
13.5.2 Biorbyt Tocilizumab Product Portfolios and Specifications
13.5.3 Biorbyt Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Biorbyt Main Business Overview
13.5.5 Biorbyt Latest Developments
13.6 AbMole
13.6.1 AbMole Company Information
13.6.2 AbMole Tocilizumab Product Portfolios and Specifications
13.6.3 AbMole Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 AbMole Main Business Overview
13.6.5 AbMole Latest Developments
13.7 Biosynth Carbosynth
13.7.1 Biosynth Carbosynth Company Information
13.7.2 Biosynth Carbosynth Tocilizumab Product Portfolios and Specifications
13.7.3 Biosynth Carbosynth Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Biosynth Carbosynth Main Business Overview
13.7.5 Biosynth Carbosynth Latest Developments
13.8 SimSon Pharma
13.8.1 SimSon Pharma Company Information
13.8.2 SimSon Pharma Tocilizumab Product Portfolios and Specifications
13.8.3 SimSon Pharma Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 SimSon Pharma Main Business Overview
13.8.5 SimSon Pharma Latest Developments
13.9 BOC Sciences
13.9.1 BOC Sciences Company Information
13.9.2 BOC Sciences Tocilizumab Product Portfolios and Specifications
13.9.3 BOC Sciences Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 BOC Sciences Main Business Overview
13.9.5 BOC Sciences Latest Developments
13.10 Clearsynth
13.10.1 Clearsynth Company Information
13.10.2 Clearsynth Tocilizumab Product Portfolios and Specifications
13.10.3 Clearsynth Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Clearsynth Main Business Overview
13.10.5 Clearsynth Latest Developments
13.11 LifeSpan BioSciences
13.11.1 LifeSpan BioSciences Company Information
13.11.2 LifeSpan BioSciences Tocilizumab Product Portfolios and Specifications
13.11.3 LifeSpan BioSciences Tocilizumab Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 LifeSpan BioSciences Main Business Overview
13.11.5 LifeSpan BioSciences Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Tocilizumab Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Tocilizumab Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Min Purity Less Than 98%
Table 4. Major Players of Min Purity 98%-99%
Table 5. Major Players of Min Purity More Than 99%
Table 6. Global Tocilizumab Sales by Type (2018-2023) & (Kg)
Table 7. Global Tocilizumab Sales Market Share by Type (2018-2023)
Table 8. Global Tocilizumab Revenue by Type (2018-2023) & ($ million)
Table 9. Global Tocilizumab Revenue Market Share by Type (2018-2023)
Table 10. Global Tocilizumab Sale Price by Type (2018-2023) & (K USD/Kg)
Table 11. Global Tocilizumab Sales by Application (2018-2023) & (Kg)
Table 12. Global Tocilizumab Sales Market Share by Application (2018-2023)
Table 13. Global Tocilizumab Revenue by Application (2018-2023)
Table 14. Global Tocilizumab Revenue Market Share by Application (2018-2023)
Table 15. Global Tocilizumab Sale Price by Application (2018-2023) & (K USD/Kg)
Table 16. Global Tocilizumab Sales by Company (2018-2023) & (Kg)
Table 17. Global Tocilizumab Sales Market Share by Company (2018-2023)
Table 18. Global Tocilizumab Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Tocilizumab Revenue Market Share by Company (2018-2023)
Table 20. Global Tocilizumab Sale Price by Company (2018-2023) & (K USD/Kg)
Table 21. Key Manufacturers Tocilizumab Producing Area Distribution and Sales Area
Table 22. Players Tocilizumab Products Offered
Table 23. Tocilizumab Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Tocilizumab Sales by Geographic Region (2018-2023) & (Kg)
Table 27. Global Tocilizumab Sales Market Share Geographic Region (2018-2023)
Table 28. Global Tocilizumab Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Tocilizumab Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Tocilizumab Sales by Country/Region (2018-2023) & (Kg)
Table 31. Global Tocilizumab Sales Market Share by Country/Region (2018-2023)
Table 32. Global Tocilizumab Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Tocilizumab Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Tocilizumab Sales by Country (2018-2023) & (Kg)
Table 35. Americas Tocilizumab Sales Market Share by Country (2018-2023)
Table 36. Americas Tocilizumab Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Tocilizumab Revenue Market Share by Country (2018-2023)
Table 38. Americas Tocilizumab Sales by Type (2018-2023) & (Kg)
Table 39. Americas Tocilizumab Sales by Application (2018-2023) & (Kg)
Table 40. APAC Tocilizumab Sales by Region (2018-2023) & (Kg)
Table 41. APAC Tocilizumab Sales Market Share by Region (2018-2023)
Table 42. APAC Tocilizumab Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Tocilizumab Revenue Market Share by Region (2018-2023)
Table 44. APAC Tocilizumab Sales by Type (2018-2023) & (Kg)
Table 45. APAC Tocilizumab Sales by Application (2018-2023) & (Kg)
Table 46. Europe Tocilizumab Sales by Country (2018-2023) & (Kg)
Table 47. Europe Tocilizumab Sales Market Share by Country (2018-2023)
Table 48. Europe Tocilizumab Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Tocilizumab Revenue Market Share by Country (2018-2023)
Table 50. Europe Tocilizumab Sales by Type (2018-2023) & (Kg)
Table 51. Europe Tocilizumab Sales by Application (2018-2023) & (Kg)
Table 52. Middle East & Africa Tocilizumab Sales by Country (2018-2023) & (Kg)
Table 53. Middle East & Africa Tocilizumab Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Tocilizumab Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Tocilizumab Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Tocilizumab Sales by Type (2018-2023) & (Kg)
Table 57. Middle East & Africa Tocilizumab Sales by Application (2018-2023) & (Kg)
Table 58. Key Market Drivers & Growth Opportunities of Tocilizumab
Table 59. Key Market Challenges & Risks of Tocilizumab
Table 60. Key Industry Trends of Tocilizumab
Table 61. Tocilizumab Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Tocilizumab Distributors List
Table 64. Tocilizumab Customer List
Table 65. Global Tocilizumab Sales Forecast by Region (2024-2029) & (Kg)
Table 66. Global Tocilizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Tocilizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 68. Americas Tocilizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Tocilizumab Sales Forecast by Region (2024-2029) & (Kg)
Table 70. APAC Tocilizumab Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Tocilizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 72. Europe Tocilizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Tocilizumab Sales Forecast by Country (2024-2029) & (Kg)
Table 74. Middle East & Africa Tocilizumab Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Tocilizumab Sales Forecast by Type (2024-2029) & (Kg)
Table 76. Global Tocilizumab Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Tocilizumab Sales Forecast by Application (2024-2029) & (Kg)
Table 78. Global Tocilizumab Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Bio-Rad Laboratories Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 80. Bio-Rad Laboratories Tocilizumab Product Portfolios and Specifications
Table 81. Bio-Rad Laboratories Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 82. Bio-Rad Laboratories Main Business
Table 83. Bio-Rad Laboratories Latest Developments
Table 84. Bio-Techne Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 85. Bio-Techne Tocilizumab Product Portfolios and Specifications
Table 86. Bio-Techne Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 87. Bio-Techne Main Business
Table 88. Bio-Techne Latest Developments
Table 89. BioVision Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 90. BioVision Tocilizumab Product Portfolios and Specifications
Table 91. BioVision Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 92. BioVision Main Business
Table 93. BioVision Latest Developments
Table 94. Selleck Chemicals Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 95. Selleck Chemicals Tocilizumab Product Portfolios and Specifications
Table 96. Selleck Chemicals Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 97. Selleck Chemicals Main Business
Table 98. Selleck Chemicals Latest Developments
Table 99. Biorbyt Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 100. Biorbyt Tocilizumab Product Portfolios and Specifications
Table 101. Biorbyt Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 102. Biorbyt Main Business
Table 103. Biorbyt Latest Developments
Table 104. AbMole Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 105. AbMole Tocilizumab Product Portfolios and Specifications
Table 106. AbMole Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 107. AbMole Main Business
Table 108. AbMole Latest Developments
Table 109. Biosynth Carbosynth Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 110. Biosynth Carbosynth Tocilizumab Product Portfolios and Specifications
Table 111. Biosynth Carbosynth Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 112. Biosynth Carbosynth Main Business
Table 113. Biosynth Carbosynth Latest Developments
Table 114. SimSon Pharma Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 115. SimSon Pharma Tocilizumab Product Portfolios and Specifications
Table 116. SimSon Pharma Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 117. SimSon Pharma Main Business
Table 118. SimSon Pharma Latest Developments
Table 119. BOC Sciences Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 120. BOC Sciences Tocilizumab Product Portfolios and Specifications
Table 121. BOC Sciences Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 122. BOC Sciences Main Business
Table 123. BOC Sciences Latest Developments
Table 124. Clearsynth Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 125. Clearsynth Tocilizumab Product Portfolios and Specifications
Table 126. Clearsynth Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 127. Clearsynth Main Business
Table 128. Clearsynth Latest Developments
Table 129. LifeSpan BioSciences Basic Information, Tocilizumab Manufacturing Base, Sales Area and Its Competitors
Table 130. LifeSpan BioSciences Tocilizumab Product Portfolios and Specifications
Table 131. LifeSpan BioSciences Tocilizumab Sales (Kg), Revenue ($ Million), Price (K USD/Kg) and Gross Margin (2018-2023)
Table 132. LifeSpan BioSciences Main Business
Table 133. LifeSpan BioSciences Latest Developments
List of Figures
Figure 1. Picture of Tocilizumab
Figure 2. Tocilizumab Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Tocilizumab Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Tocilizumab Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Tocilizumab Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Min Purity Less Than 98%
Figure 10. Product Picture of Min Purity 98%-99%
Figure 11. Product Picture of Min Purity More Than 99%
Figure 12. Global Tocilizumab Sales Market Share by Type in 2022
Figure 13. Global Tocilizumab Revenue Market Share by Type (2018-2023)
Figure 14. Tocilizumab Consumed in Research
Figure 15. Global Tocilizumab Market: Research (2018-2023) & (Kg)
Figure 16. Tocilizumab Consumed in Medical
Figure 17. Global Tocilizumab Market: Medical (2018-2023) & (Kg)
Figure 18. Global Tocilizumab Sales Market Share by Application (2022)
Figure 19. Global Tocilizumab Revenue Market Share by Application in 2022
Figure 20. Tocilizumab Sales Market by Company in 2022 (Kg)
Figure 21. Global Tocilizumab Sales Market Share by Company in 2022
Figure 22. Tocilizumab Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Tocilizumab Revenue Market Share by Company in 2022
Figure 24. Global Tocilizumab Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Tocilizumab Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Tocilizumab Sales 2018-2023 (Kg)
Figure 27. Americas Tocilizumab Revenue 2018-2023 ($ Millions)
Figure 28. APAC Tocilizumab Sales 2018-2023 (Kg)
Figure 29. APAC Tocilizumab Revenue 2018-2023 ($ Millions)
Figure 30. Europe Tocilizumab Sales 2018-2023 (Kg)
Figure 31. Europe Tocilizumab Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Tocilizumab Sales 2018-2023 (Kg)
Figure 33. Middle East & Africa Tocilizumab Revenue 2018-2023 ($ Millions)
Figure 34. Americas Tocilizumab Sales Market Share by Country in 2022
Figure 35. Americas Tocilizumab Revenue Market Share by Country in 2022
Figure 36. Americas Tocilizumab Sales Market Share by Type (2018-2023)
Figure 37. Americas Tocilizumab Sales Market Share by Application (2018-2023)
Figure 38. United States Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Tocilizumab Sales Market Share by Region in 2022
Figure 43. APAC Tocilizumab Revenue Market Share by Regions in 2022
Figure 44. APAC Tocilizumab Sales Market Share by Type (2018-2023)
Figure 45. APAC Tocilizumab Sales Market Share by Application (2018-2023)
Figure 46. China Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Tocilizumab Sales Market Share by Country in 2022
Figure 54. Europe Tocilizumab Revenue Market Share by Country in 2022
Figure 55. Europe Tocilizumab Sales Market Share by Type (2018-2023)
Figure 56. Europe Tocilizumab Sales Market Share by Application (2018-2023)
Figure 57. Germany Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Tocilizumab Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Tocilizumab Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Tocilizumab Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Tocilizumab Sales Market Share by Application (2018-2023)
Figure 66. Egypt Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Tocilizumab Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Tocilizumab in 2022
Figure 72. Manufacturing Process Analysis of Tocilizumab
Figure 73. Industry Chain Structure of Tocilizumab
Figure 74. Channels of Distribution
Figure 75. Global Tocilizumab Sales Market Forecast by Region (2024-2029)
Figure 76. Global Tocilizumab Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Tocilizumab Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Tocilizumab Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Tocilizumab Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Tocilizumab Revenue Market Share Forecast by Application (2024-2029)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のトシリズマブ市場予測 2023年-2029年(Global Tocilizumab Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

世界のトシリズマブ市場予測 2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp